Description

Methyl 2-(4-Fluorophenyl)-3-Oxo-1,2,3,4-Tetrahydroquinoxaline-6-Carboxylate is a high-purity, advanced pharmaceutical intermediate characterized by its unique quinoxaline core structure. This compound is of significant commercial importance for its role as a critical building block in the synthesis of novel active pharmaceutical ingredients (APIs). It is primarily utilized by research institutions and pharmaceutical manufacturers engaged in the development of new therapeutic agents, particularly within medicinal chemistry and process R&D.

Application

• Pharmaceutical Intermediate: Serves as a key precursor in the synthesis of complex drug candidates, particularly those targeting central nervous system (CNS) disorders and other therapeutic areas.
• Medicinal Chemistry Research: Used as a scaffold for structure-activity relationship (SAR) studies and lead optimization in drug discovery programs.
• Process Chemistry Development: Employed in route scouting, scale-up, and optimization for the commercial manufacturing of target APIs.
• Chemical Reference Standard: Acts as a high-purity analytical standard for quality control and method validation in pharmaceutical analysis.
• Organic Synthesis Building Block: Utilized in academic and industrial research for constructing complex heterocyclic compounds due to its reactive functional groups.

Basic Information

Product Name	Methyl 2-(4-Fluorophenyl)-3-Oxo-1,2,3,4-Tetrahydroquinoxaline-6-Carboxylate
CAS No.	1268867-01-1
Molecular Formula	C₁₆H₁₃FN₂O₃
Molecular Weight	300.29 g/mol
Synonyms	Methyl 2-(4-fluorophenyl)-3-oxo-1,2,3,4-tetrahydroquinoxaline-6-carboxylate; 6-Carbomethoxy-2-(4-fluorophenyl)-1,2,3,4-tetrahydro-3-quinoxalinone; 2-(4-Fluorophenyl)-3-oxo-1,2,3,4-tetrahydroquinoxaline-6-carboxylic acid methyl ester; 1,2,3,4-Tetrahydro-2-(4-fluorophenyl)-3-oxoquinoxaline-6-carboxylic acid methyl ester; Methyl 2-(p-fluorophenyl)-3-oxo-1,2,3,4-tetrahydro-6-quinoxalinecarboxylate; CAS 1268867-01-1
EINECS	Contact for details

Quality Control

Our Methyl 2-(4-Fluorophenyl)-3-Oxo-1,2,3,4-Tetrahydroquinoxaline-6-Carboxylate is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the high standards required for pharmaceutical R&D and manufacturing. Certificates of Analysis (COA) detailing batch-specific results are available upon request, providing full traceability and compliance data.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (15-25°C). Keep the container tightly sealed to protect from moisture.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.